PRAVEENA GADAM: Open Payments
NPI 1669709853 · COLUMBIA, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,865 in 243 payments from 19 companies in 2025. Trend: 2023 $5,126 · 2024 $4,817 · 2025 $4,865
Food & beverage: $4,835Education: $30
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $510 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 18 | $439 |
| Lundbeck LLC | 26 | $437 |
| Axsome Therapeutics, Inc. | 19 | $435 |
| Alkermes, Inc. | 32 | $427 |
| Teva Pharmaceuticals USA, Inc. | 20 | $400 |
| Vanda Pharmaceuticals Inc. | 15 | $365 |
| Neurocrine BioSciences, Inc. | 11 | $304 |
| E.R. Squibb & Sons, L.L.C. | 9 | $261 |
| Janssen Pharmaceuticals, Inc | 9 | $208 |
Products named: VRAYLAR, CAPLYTA, ARISTADA, Auvelity, FANAPT, INGREZZA, REXULTI, COBENFY.
Industry payments across MD — which companies pay providers there.
